Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I

Journal of Infectious Diseases

Volumn 193, Issue 3, 2006, Pages 427-437

  Yao, Karen ^a,d   Hisada, Michie ^b   Maloney, Elizabeth ^b,f   Yamano, Yoshihisa ^a,g   Hanchard, Barrie ^e   Wilks, Rainford ^e   Rios, Maria ^c   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF THE WEST INDIES   (Jamaica)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HLA A ANTIGEN; PROTEIN GD21; PROTEIN P19; PROTEIN RGP46; TETRAMER; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENVELOPE GENE; EXPOSURE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVIRUS; SYMPTOMATOLOGY; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; WESTERN BLOTTING;

BLOOD DONORS; BLOOD TRANSFUSION; BLOTTING, WESTERN; DNA, VIRAL; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; NERVOUS SYSTEM DISEASES; PROVIRUSES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 31044433699     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/499273     Document Type: Article

References (40)

1. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353:1951-8.
2. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407-10.
3. Tajima K, Cartier L. Epidemiological features of HTLV-I and adult T cell leukemia. Intervirology 1995; 38:238-46.
4. Osame M, Izumo S, Igata A, et al. Blood transfusion and HTLV-I associated myelopathy. Lancet 1986; 2:104-5.
5. Maloney EM, Armien B, Gracia F, et al. Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama. J Infect Dis 1999; 180:876-9.
6. Leon-Ponte M, Noya O, Bianco N, Echeverria de Perez G. Highly endemic human T-lymphotropic virus type II (HTLV-II) infection in a Venezuelan Guahibo Amerindian group. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:281-6.
7. Briggs NC, Battjes RJ, Cantor KP, et al. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users. J Infect Dis 1995; 172:51-8.
8. Black FL, Biggar RJ, Lal RB, Gabbai AA, Filho JP. Twenty-five years of HTLV type II follow-up with a possible case of tropical spastic paraparesis in the Kayapo, a Brazilian Indian tribe. AIDS Res Hum Retroviruses 1996; 12:1623-7.
9. Orland JR, Engstrom J, Fridey J, et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 2003; 61:1588-94.
10. Rouet F, Meertens L, Courouble G, et al. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean. J Clin Microbiol 2001;39:1247-53.
11. Lal RB, Rudolph D, Alpers MP, Sulzer AJ, Shi YP, Lal AA. Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum. Clin Diagn Lab Immunol 1994; 1:5-10.
12. Soldan SS, Graf MD, Waziri A, et al. HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease. J Infect Dis 1999; 180:685-94.
13. Garin B, Gosselin S, de The G, Gessain A. HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: comparative evaluation of serology, PCR, and significance of indeterminate Western blot pattern. J Med Virol 1994; 44:104-9.
14. Caterino-de-Araujo A, de los Santos-Fortuna E, Meleiro MC, et al. Sensitivity of two enzyme-linked immunosorbent assay tests in relation to western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from Sao Paulo, Brazil. Diagn Microbiol Infect Dis 1998; 30:173-82.
15. Cesaire R, Bera O, Maier H, et al. Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies. Transfusion 1999; 39:1145-9.
16. Cohen CJ, Sarig O, Yamano Y, Tomaru U, Jacobson S, Reiter Y. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies. J Immunol 2003; 170:4349-61.
17. Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Am J Trop Med Hyg 1997; 57:142-8.
18. Mangano AM, Remesar M, del Pozo A, Sen L. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. J Med Virol 2004; 74:323-7.
19. Waziri A, Soldan SS, Graf MD, Nagle J, Jacobson S. Characterization and sequencing of prototypic human T-lymphotropic virus type 1 (HTLV-1) from an HTLV-1/2 seroindeterminate patient. J Virol 2000; 74:2178-85.
20. Mahieux R, Horal P, Mauclere P, et al. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection. J Clin Microbiol 2000; 38:4049-57.
21. Morozov VA, Ellerbrok H, Fleischer C, Brackmann HH, Pauli G. Defective human T-cell leukaemia virus type I (HTLV-I) genomes: no evidence in serologically indeterminate German blood donors but new type detected in established cell lines. J Med Virol 2002; 66:102-6.
22. Ramirez E, Cartier L, Rios M, Fernandez J. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in 10 Chilean seronegative patients with tropical spastic paraparesis or HTLV-I-associated myelopathy. J Clin Microbiol 1998; 36:1811-3.
23. Ramirez E, Fernandez J, Cartier L, Villota C, Rios M. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients. Virus Res 2003; 91:231-9.
24. Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992; 51:886-91.
25. Rios M, Khabbaz RF, Kaplan JE, Hall WW, Kessler D, Bianco C. Transmission of human T cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I-screened blood products. J Infect Dis 1994; 170:206-10.
26. Puccioni-Sohler M, Rios M, Bianco C, et al. An inverse correlation of HTLV-I viral load in CSF and intrathecal synthesis of HTLV-I antibodies in TSP/HAM. Neurology 1999; 53:1335-9.
27. Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S. Increased HTLV type 1 tax specific CD8 cells in HTLV type I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. AIDS Res Hum Retroviruses 2000; 16:1705-9.
28. Kubota R, Soldan SS, Martin R, Jacobson S. Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient. J Neurovirol 2002; 8:53-7.
29. Jacobson S, McFarlin DE, Robinson S, et al. HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-asociated neurological disease. Ann Neurol 1992; 32:651-7.
30. Lal RB, Rudolph DL, Coligan JE, Brodine SK, Roberts CR. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II. Blood 1992; 80:544-50.
31. Lal RB, Brodine S, Kazura J, Mbidde-Katonga E, Yanagihara R, Roberts C. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked Western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections. J Clin Microbiol 1992; 30:296-9.
32. + T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002; 99:88-94.
33. Khabbaz RF, Heneine W, Grindon A, Hartley TM, Shulman G, Kaplan J. Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-II or HTLV-II? J Acquir Immune Defic Syndr 1992; 5: 400-4.
34. + cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis 2001; 183:197-205.
35. Ureta-Vidal A, Pique C, Garcia Z, et al. Human T cell leukemia virus type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers. J Infect Dis 2001; 183: 857-64.
36. Biddison WE, Kubota R, Kawanishi T, et al. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 1997; 159:2018-25.
37. Rhodes D, Solomon A, Bolton W, et al. Identification of a new recipient in the Sydney Blood Bank Cohort: a long-term HIV type 1-infected seroindeterminate individual. AIDS Res Hum Retroviruses 1999; 15: 1433-9.
38. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993; 33:392-6.
39. Murphy EL, Glynn SA, Fridey J, et al. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study. Arch Intern Med 1999; 159:1485-91.
40. Biglione MM, Pizarro M, Salomón HE, Berría MI. A possible case of myelopathy/tropical spastic paraparesis in an Argentinian woman with human T lymphocyte virus type II. Clin Infect Dis 2003; 3 7:456-8.